Form 4: IDEXX Laboratories Director Daniel M. Junius Reports Stock Transactions

Director Daniel M. Junius reports acquisition and disposal of IDEXX Laboratories stock and derivative securities.

Summary

• On May 6, 2025, Director Daniel M. Junius engaged in transactions involving IDEXX Laboratories, Inc. stock.
• Junius disposed of 262 shares of common stock.
• Following the transaction, Junius beneficially owns 3,304 shares of common stock.
• Junius also acquired 600 non-qualified stock options with an exercise price of $486.61, exercisable from May 7, 2025, and expiring on May 6, 2035.
• Additionally, Junius acquired 257 restricted stock units, each representing a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company leadership.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates

Keywords

IDEXX Laboratories, IDXX, Daniel M. Junius, Form 4, Stock Options, Restricted Stock Units, Director, Beneficial Ownership, Securities